HERPES ZOSTER MENINGOMYELITIS

HERPES ZOSTER MENINGOMYELITIS was reported 43 times

HERPES ZOSTER MENINGOMYELITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 1 0.0008
1 Type I Interferon Receptor Antagonist [EPC] 1 0.0005
2 CD52-directed Cytolytic Antibody [EPC] 3 0.0002
3 CD30-directed Immunoconjugate [EPC] 1 0.0001
4 B Lymphocyte Stimulator-specific Inhibitor [EPC] 2 0.0001
5 Integrin Receptor Antagonist [EPC] 4 0.0000
6 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
7 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
8 Potassium Channel Blocker [EPC] 1 0.0000
9 Janus Kinase Inhibitor [EPC] 2 0.0000
10 Corticosteroid [EPC] 14 0.0000
11 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
12 Aminosalicylate [EPC] 1 0.0000
13 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
14 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
15 Leukocyte Growth Factor [EPC] 1 0.0000
16 Proton Pump Inhibitor [EPC] 3 0.0000
17 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
18 Alkylating Drug [EPC] 1 0.0000
19 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
20 Osmotic Laxative [EPC] 1 0.0000
21 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
22 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
23 Insulin Analog [EPC] 1 0.0000
24 Thalidomide Analog [EPC] 1 0.0000
25 Kinase Inhibitor [EPC] 1 0.0000
26 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
27 Benzodiazepine [EPC] 1 0.0000